GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Prestige Consumer Healthcare PBH · USD

Health Care · US listing · 🇺🇸 United States

Compare

43.67

+1.61%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$1.09bn

FY2017FY2026

Net income

$190.3m

FY2017FY2026

Free cash flow

$246.4m

FY2017FY2026

Shareholders' equity

$1.89bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$1.09bn$1.14bn$1.13bn$1.13bn$1.09bn$943.4m$963.0m$975.8m$1.04bn$882.1m
Gross profit$574.6m$634.5m$624.4m$625.3m$620.6m$547.5m$552.2m$555.6m$576.5m$500.3m
Operating income$309.4m$336.8m$342.4m−$24.8m$329.9m$297.4m$291.2m$67.5m$215.9m$205.6m
Net income$190.3m$214.6m$209.3m−$82.3m$205.4m$164.7m$142.3m−$35.8m$339.6m$69.4m
Diluted earnings per share4.004.464.19-1.644.093.232.81-0.706.501.30

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$3.55bn$3.40bn$3.32bn$3.35bn$3.67bn$3.43bn$3.51bn$3.44bn$3.76bn$3.91bn
Cash and short-term investments$63.9m$97.9m$46.5m$58.5m$27.2m$32.3m$94.8m$27.5m$32.5m$41.9m
Total liabilities$1.66bn$1.57bn$1.66bn$1.91bn$2.09bn$2.07bn$2.34bn$2.35bn$2.58bn$3.09bn
Debt$1.01bn$1.02bn$1.13bn$1.35bn$1.48bn$1.49bn$1.74bn$1.80bn$1.99bn$2.19bn
Shareholders' equity$1.89bn$1.83bn$1.66bn$1.45bn$1.58bn$1.36bn$1.17bn$1.10bn$1.18bn$822.5m
Shares outstanding48m48m50m50m50m51m51m51m52m54m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$257.6m$251.5m$248.9m$229.7m$259.9m$235.6m$217.1m$189.3m$210.1m$147.8m
Capital spending−$11.2m−$8.2m−$9.6m−$7.8m−$9.6m−$22.2m−$14.6m−$10.5m−$12.5m−$3.0m
Free cash flow$246.4m$243.3m$239.4m$221.9m$250.3m$213.4m$202.6m$178.8m$197.6m$144.8m
Dividends paid————−$4.1m−$2.9m−$1.3m−$2.9m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$265.7m$281.6m$283.4m$274.1m$249.5m$296.8m$290.3m$283.5m
Gross profit$136.2m$140.9m$157.4m$154.1m$135.1m$175.7m$161.0m$157.4m
Operating income$52.5m$75.5m$82.5m$79.7m$71.8m$88.4m$92.0m$84.3m
Net income$29.2m$53.9m$46.7m$42.2m$47.5m$50.1m$61.0m$54.4m
Diluted earnings per share0.611.130.970.880.991.041.221.09
Cash from operations$70.0m$42.0m$78.0m$57.0m$79.0m$61.0m$65.0m$69.0m
Capital spending−$3.0m−$5.0m−$3.0m−$2.0m—−$3.0m−$1.0m−$2.0m
Free cash flow$67.0m$37.0m$75.0m$55.0m—$58.0m$64.0m$67.0m
Total assets$4.57bn$3.55bn$3.49bn$3.44bn$3.43bn$3.40bn$3.33bn$3.32bn
Cash and short-term investments$89.1m$63.9m$62.4m$119.1m$139.5m$97.9m$50.9m$51.5m
Debt$2.03bn$1.01bn$1.06bn$1.02bn$1.02bn$1.02bn$1.00bn$1.05bn
Shareholders' equity$1.92bn$1.89bn$1.83bn$1.82bn$1.86bn$1.83bn$1.79bn$1.73bn

Financial ratios

Data as of 23 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin52.8%55.8%55.5%55.4%57.1%58.0%
Operating margin27.5%29.2%30.5%-2.2%30.1%30.4%
Net margin17.5%18.9%18.6%-7.3%18.9%17.5%
Return on equity10.1%11.7%12.6%-5.7%13.0%12.1%
Return on assets5.4%6.3%6.3%-2.5%5.6%4.8%
Free cash flow yield11.4%10.9%10.5%9.6%10.9%10.2%
Revenue growth-4.3%1.1%-0.2%3.8%15.2%-2.0%
Earnings growth-11.3%2.5%-354.3%-140.1%24.7%15.7%
Current ratio3.57x4.20x3.20x2.44x2.04x2.21x
Debt to equity0.53x0.55x0.68x0.94x0.94x1.10x
Equity ratio53.2%53.9%49.9%43.1%43.0%39.6%
Interest coverage7.08x6.97x5.11x-0.36x5.08x3.48x
Buybacks as a share of market value1.0%3.8%0.3%0.1%1.5%-0.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.2%2.9%3.0%
Operating income—0.8%1.7%
Net income—2.9%6.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin54.3%54.9%55.7%56.2%
Operating margin29.0%21.5%24.4%23.5%
Net margin18.2%11.9%13.9%13.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings13.313.818.6-37.315.318.812.4-57.54.834.3
Price to sales2.32.63.52.72.93.31.82.11.62.7

Market value over time

31 Oct 2016 to 22 Oct 2026, in USD

$2.42bn$2.35bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-21%29%-1%2%73%-13%31%-31%-10%-0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 28 Sept 2015.

FY2016
Paid in the year0.345

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.